Media Publications - Critical Path Institute

January 15, 2025

C-Path Welcomes Bayer Pharma as Newest Member of CPP

C-Path is excited to welcome Bayer Pharma as a the newest member of the organization's Critical Path for Parkinson’s (CPP) Conso

New Funding Opportunity for Drug Development Projects TUCSON, Ariz., January 14, 2025 – Critical Path Institute’s® (C-Path) T

January 12, 2025

Every year on January 12th, we pause to celebrate National Pharmacist Day — a day dedicated to recognizing the vital role pharma

January 28, 2025

Join us on January 28th at 10am EST as C-Path’s Translational Therapeutics Accelerator...

December 13, 2024

In the rapidly evolving landscape of healthcare and drug development, the ability to efficiently collect...

December 12, 2024

This event featured Dr. Volker Straub, a renowned neuromuscular genetics expert...

November 27, 2024

Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...

November 27, 2024

The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..

December 10, 2024

Biomarkers are emerging as powerful tools in the field of kidney health, playing a crucial role in the diagnosis, monitoring...

November 27, 2024

Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...